Doud­na re­search team finds CRISPR-Csm de­liv­ery po­ten­tial­ly out­per­forms RNAi, Cas13

While RNAi and Cas13 have been used as some of the ear­ly meth­ods for gene si­lenc­ing, a new preprint from top re­searchers says there might be some­thing bet­ter com­ing down the pike.

A group of UC Berke­ley re­searchers, com­pris­ing famed bio­chemist and No­bel Prize win­ner Jen­nifer Doud­na and her lab mem­bers David Colog­nori and Mare­na Trinidad, has de­scribed a new method that can pro­vide po­ten­tial­ly safer and more ef­fi­cient gene edit­ing: CRISPR-Csm.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER